SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Cardium Therapeutics has sold its To Go Brands subsidiary in a deal worth $2.5 million.
Tech Coast Angels, a group of private investors with a chapter in San Diego, said it recently invested about $1 million in two local startups, SeniorQuote Insurance Services and Rock My World.
Shares for San Diego’s Cadence Pharmaceuticals Inc. shot up 34 percent — to a two year high — following a favorable ruling from the U.S. District Court for the District of Delaware in a patent lawsuit against Exela Pharma Sciences Inc.
San Diego-based Illumina Inc.’s 13.5 percent stake in its rival Oxford Nanopore Technologies Ltd. has been sold to other investors.
Biotech: Researchers, Investors Still Waiting for Effective Therapies
San Diego is a beacon nationally for its advances in regenerative medicine and stem cell research, but the field has faltered in its transition from the bench to the bedside.
HEALTH: Acquisition Would Bring More Services To Rural Area Residents
Scripps Health could acquire El Centro Regional Medical Center, a 161-bed hospital that’s been shopping for a buyer since May.
North County Health Services will begin a $7.5 million overhaul of its Mission Mesa campus in Oceanside, which it said will more than quadruple the size of the community clinic. It plans to break ground in early December.
Biotechnology/Health Care Column
Some happy news for the biotech IPO circuit: On its first day of trading on the Nasdaq, shares for Tandem Diabetes Care Inc. soared 28 percent — or $4.26 — closing day trading at $19.26. It trades on the Nasdaq under ticker symbol TNDM.
On its first day of trading on the Nasdaq, shares for Tandem Diabetes Care Inc. soared 28 percent — or $4.26 — closing day trading at $19.26.
San Diego-based Celladon Corp. has chosen to postpone its $75 million initial public offering, citing poor market conditions, according to equity research firm Renaissance Capital.
San Diego-based Sorrento Therapeutics announced it is acquiring Concortis BioSystems, a San Diego biotech, in a deal worth about $12 million.
San Diego-based Tandem Diabetes Care Inc. has upped the ante of its previously announced initial public offering, increasing the targeted goal from $100 million to $120 million.
Shares for San Diego biotech Organovo Inc. jumped as much as 17 percent in day trading after settling in at a 4 percent increase following the company’s release of its second quarter results.
San Diego DNA sequencing company Illumina Inc. has appointed Francis deSouza, a Bay Area computer security executive, as its president. He will join the company in December.
Shares for San Diego’s Arena Pharmaceuticals Inc. continue to rise following its Nov. 7 announcement that it will expand its partnership with Japanese drugmaker Eisai Co. to market the anti-obesity medication Belviq.